Ethicon
Search results
Discover how the revolutionary products & solutions by ACCLARENT® help amplify the unique skills of ENT surgeons enabling safe, fast & effective treatments.
Change your tool, not your technique. The ACCLARENT PIVOT™ is an integrated balloon sinuplasty (BSP) and Eustachian tube balloon dilation (ETBD) device, available in light fiber and navigation guidewire configurations for compatibility with illumination and navigation technology.
Acclarent, Inc. began as a privately held, venture-backed company, and is now a subsidiary of Integra LifeSciences. Based in Irvine, Orange County, California. [1] it develops technology for ENT (Ear, Nose and Throat) related illnesses.
Acclarent, Inc., part of Integra LifeSciences, is a medical device company in Irvine, CA that was established in June of 2004. We’re dedicated to supporting Ear, Nose, and Throat (ENT) surgeons...
Apr 1, 2024 · Integra LifeSciences, a global medical technology company, announces the completion of its acquisition of Acclarent, a pioneer in ENT surgical interventions. The acquisition expands Integra's market-leading brands, addressable market and growth opportunities in the ENT device segment.
Apr 1, 2024 · Integra LifeSciences, a global medical technology company, completes the acquisition of Acclarent, a pioneer in ENT surgical interventions. The deal expands Integra's market-leading brands, addressable market and growth opportunities in the ENT device segment.
Dec 13, 2023 · Integra LifeSciences announced a definitive agreement to buy Acclarent, a Johnson & Johnson MedTech company, for $275 million in cash and $5 million in milestones. Acclarent is a market leader in ENT procedures and products, such as balloon technologies for sinus and eustachian tube dilation.
